APVO - Aptevo Therapeutics GAAP EPS of -$1.59 misses by $0.66 revenue of $3.11M misses by $0.64M
Aptevo Therapeutics press release (NASDAQ:APVO): Q1 GAAP EPS of -$1.59 misses by $0.66. Revenue of $3.11M (+28.5% Y/Y) misses by $0.64M.
For further details see:
Aptevo Therapeutics GAAP EPS of -$1.59 misses by $0.66, revenue of $3.11M misses by $0.64M